CBUS
Cibus, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.31
−0.76%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 8.50x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 6.76x
- Price / sales
- 23.03x
- Price / cash flow
- -2.17x
Enterprise value
- Enterprise value
- $112.4M
- EV / sales
- 25.86x
- EV / EBITDA
- -1.95x
- EV / EBIT
- -2.08x
- Market cap
- $100.1M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026